Inflazome
Inflazome is a biotech company that develops orally available drugs to address inflammatory diseases by targeting inflammasomes. The company's drugs block inflammasome signals, eliminating a root cause of inflammation, enabling healthcare institutions to avail targeted therapies for inflammatory diseases such as Parkinson's, Alzheimer's, atherosclerosis, and type 2 diabetes. The company was incorporated in 2016 and is headquartered in Dublin, Ireland.
Tech Stack (11 technologies)
Frequently Asked Questions
What technologies does Inflazome use?+
Inflazome uses 11 technologies including Datadog, Google Analytics, Google Tag Manager.
What industry is Inflazome in?+
Inflazome operates in the Biopharma industry.
Where is Inflazome based?+
Inflazome is headquartered in Ireland.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026